We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Use of DICOM Images for Pathology Diagnostics Marks Significant Step towards Standardization

By LabMedica International staff writers
Posted on 01 May 2024

Digital pathology is rapidly becoming a key aspect of modern healthcare, transforming the practice of pathology as laboratories worldwide adopt this advanced technology. More...

Digital pathology systems allow for the immediate and remote access to digital images of tissue samples, moving away from traditional physical glass slides that require microscope examination. The COVID-19 pandemic underscored the importance and utility of remote capabilities in pathology, significantly accelerating the adoption of digital pathology in the U.S. and boosting its market growth internationally.

Now, Sectra’s (Linköping, Sweden) digital pathology solution, along with Leica Biosystems’ (Nussloch, Germany) Aperio GT 450 DX, has received a 510(k) clearance by the US Food & Drug Administration (FDA). This marks the first FDA clearance within digital pathology that allows DICOM images to be used for pathology diagnostics and is a significant step towards standardization in this field. The Aperio GT 450, previously available under enforcement discretion due to the pandemic, is a well-established technology that delivers high-quality images at a fast turnaround time of less than 32 seconds per slide.

Leica Biosystems is not new to the regulated system market; the company boasts 25 years of experience in the digital pathology sector, where it has been integral in implementing, integrating, and innovating technologies that enhance cancer diagnosis and patient care. Sectra’s digital pathology solution is part of its broader enterprise imaging solution, designed to support a comprehensive approach to all imaging needs while reducing operational costs. This scalable and modular solution, centered around a versatile vendor-neutral archive (VNA), enables healthcare providers to grow from ology to ology and from enterprise to enterprise.

"There is no better time for laboratories to optimize their workflow with digital," said Naveen Chandra, Vice President and General Manager of Digital Pathology at Leica Biosystems. "Today, clinicians are faced with having to do more with less – digital pathology enables them to maintain a high standard of quality with world class images and a fast turnaround time, for the best patient care possible."

"Sectra has a strong track record of promoting and enabling open integrations and of pushing the development towards standardization within medical imaging IT. The recent FDA clearance including the clearance to utilize DICOM images for pathology diagnostics therefore makes me very proud,” said Dr. Torbjörn Kronander, CEO and President Sectra AB. “Due to the unique nature of the images used in digital pathology, proprietary formats have previously dominated. This FDA approval, including DICOM, shows that standardization is possible also within pathology. This is an important first step to a reality where healthcare providers can start reaping the benefits of a larger degree of freedom in choosing what hardware and software to combine, within pathology. This has the potential to increase workflow efficiency, facilitate the adoption of new technology and in the end—benefit patient care."

 


New
Gold Member
Latex Test
SLE-Latex Test
Serological Pipet Controller
PIPETBOY GENIUS
New
Droplet Digital PCR System
QX600 AutoDG
New
Glucose Tolerance Test
NERL Trutol
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The LEX VELO system aims to redefine point-of-care testing (Photo courtesy of LEX Diagnostics)

POC System Delivers Lab-Quality PCR Results Directly from Swab Sample in Minutes

Medical and laboratory staff in primary care settings are multi-skilled and routinely multitask to deliver care with the speed and convenience expected of modern medicine. This places a strong requirement... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The tip optofluidic immunoassay platform enables rapid, multiplexed antibody profiling using only 1 μL of fingertip blood (Photo courtesy of hLife, DOI:10.1016/j.hlife.2025.04.005)

POC Diagnostic Platform Performs Immune Analysis Using One Drop of Fingertip Blood

As new COVID-19 variants continue to emerge and individuals accumulate complex histories of vaccination and infection, there is an urgent need for diagnostic tools that can quickly and accurately assess... Read more

Technology

view channel
Image: The machine learning-based method delivers near-perfect survival estimates for PAC patients (Photo courtesy of Shutterstock)

AI Method Predicts Overall Survival Rate of Prostate Cancer Patients

Prostate adenocarcinoma (PAC) accounts for 99% of prostate cancer diagnoses and is the second most common cancer in men globally after skin cancer. With more than 3.3 million men in the United States diagnosed... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.